|

Chlorhexidine gluconate (4%) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Hibiclens

Pipeline

Phase 3: 1

Top Sponsors

  • The Cooper Health System1

Indications

  • Surgical Wound Infection1
  • Cancer1

Marlton, New Jersey1 trial

The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal

The Center for Dermatologic Surgery at Cooper University Health Care

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.